Literature DB >> 6537691

In vitro drug sensitivity of tumor cells is correlated with drug-induced inhibition of DNA synthesis.

D B Brown, P N Rao.   

Abstract

The objective of this study was to develop a rapid in vitro method for predicting the response of human tumors to anticancer drugs. In this study an attempt was made to correlate the drug effects on the relative incorporation of (3H) thymidine (ThdR) into DNA with the sensitivity of tumor cells to that drug. The results of the study indicate that following treatment of the cells with adriamycin (ADR) or 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1 nitrosourea (MeCCNU), there was a significant inhibition of DNA synthesis in the drug-sensitive cells. However, the inhibition was relatively small in the drug-resistant cells. Following cytosine arabinoside (Ara-C) treatment, a dramatic recovery in the rate of DNA synthesis was seen in Ara-C-resistant cells but not in cells sensitive to Ara-C. Thus, the method described in this study appears to be capable of distinguishing whether a tumor cell line is sensitive or resistant to a given drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6537691      PMCID: PMC2589785     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  12 in total

1.  Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia.

Authors:  M Inaba; Y Sakurai
Journal:  Cancer Lett       Date:  1979-12       Impact factor: 8.679

2.  Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.

Authors:  L J Wilkoff; E A Dulmadge
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

3.  1-beta-D-arabinofuranosylcytosine stimulates thymidine incorporation into the DNA of contact-inhibited cells.

Authors:  D A Foster
Journal:  Exp Cell Res       Date:  1981-10       Impact factor: 3.905

4.  The Hela DNA-synthesis inhibition test as a rapid screen for mutagenic carcinogens.

Authors:  R B Painter; R Howard
Journal:  Mutat Res       Date:  1982-02-22       Impact factor: 2.433

5.  Aberrant double replication of segments of chromosomal DNA following DNA synthesis inhibition by cytosine arabinoside.

Authors:  D M Woodcock; I A Cooper
Journal:  Exp Cell Res       Date:  1979-10-01       Impact factor: 3.905

6.  Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.

Authors:  M Volm; K Wayss; M Kaufmann; J Mattern
Journal:  Eur J Cancer       Date:  1979-07       Impact factor: 9.162

7.  DNA synthesis inhibition in HeLa cells as a simple test for agents that damage human DNA.

Authors:  R B Painter
Journal:  J Environ Pathol Toxicol       Date:  1978 Sep-Oct

8.  Differential repair of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea-induced DNA damage in two human colon tumor cell lines.

Authors:  L C Erickson; R Osieka; K W Kohn
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

9.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

10.  Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

Authors:  S E Salmon; A W Hamburger; B Soehnlen; B G Durie; D S Alberts; T E Moon
Journal:  N Engl J Med       Date:  1978-06-15       Impact factor: 91.245

View more
  1 in total

1.  In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture.

Authors:  R A Vescio; C H Redfern; T J Nelson; S Ugoretz; P H Stern; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.